Shattuck Labs, Inc. (STTK)
Shattuck Labs, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Shattuck Labs, Inc. (STTK) is a Biotechnology company based in US with a market capitalization of $345.4M. Revenue declined 82.5% year-over-year and free cash flow was negative at -$40M. This page tracks STTK's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 44 employees · IPO Oct 9, 2020
Valuation
Valuation & price
$6.26as of May 17, 2026· -20.6% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
4.19
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$345.4M
Market cap
-82.5%
Revenue growth (YoY)
100.0%
Gross margin
-$40M
Free cash flow (USD)
-$76.5M
Net debt
Net cash position
37.1%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2018 → 2025
Free cash flow by year
2018 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
3
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 7, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJul 7, 2026Filing
Insider Sell $3K · 10b5-1 PlanShukla Abhinav A. · Chief Technical Officer · $2.9K
- Insider sellJul 2, 2026Filing
Insider Sell $210K · 10b5-1 PlanPandite Arundathy N. · Chief Medical Officer · $210.3K
- Insider sellJul 2, 2026Filing
Insider Sell $166K · 10b5-1 PlanShukla Abhinav A. · Chief Technical Officer · $166.1K
- 8-K eventJun 11, 2026Filing
Stock Offering
- 8-K eventJun 9, 2026Filing
Phase 1 Clinical Trial Results
- 8-K eventJun 2, 2026Filing
Equity Incentive Plan Amended
- 8-K eventMay 7, 2026Filing
Earnings Release
- Quarterly reportMay 7, 2026Filing
10-Q Filed
Questions
Frequently asked questions
What is Shattuck Labs, Inc.'s market cap?
Shattuck Labs, Inc. (STTK) has a market capitalization of $345.4M.
What is STTK's P/E ratio?
A meaningful P/E ratio is not available for STTK — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is STTK's price-to-book (P/B) ratio?
STTK trades at 4.19 times book value per share.
Are insiders buying STTK stock?
SEC Form 4 filings show no open-market insider buys at Shattuck Labs, Inc. in the last 90 days (3 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.